HEPION PHARMACEUTICALS, INC.

Profile

Company Names

HEPION PHARMACEUTICALS, INC.
CONTRAVIR PHARMACEUTICALS, INC.

Addresses

34 SHREWSBURY AVE., SUITE 1D, RED BANK, NJ 07701

399 THORNALL STREET, 1ST FLOOR, EDISON, NJ 08837

399 THORNALL STREET, FIRST FLOOR, EDISON, NJ 08837

420 LEXINGTON AVENUE, SUITE 300, NEW YORK, NY 10170

420 LEXINGTON AVENUE, SUITE 2012, NEW YORK, NY 10170

Phone Numbers

732-902-4000
(732) 902-4000
212-297-6149
212-297-0020

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$46,817,652.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2026-04-21 
$700,000.00 
$700,000.00 
$0.00 
Equity 
7
2024-07-19 
$2,900,000.00 
$2,900,000.00 
$0.00 
Equity, Debt 
6
2023-09-28 
$5,000,004.00 
$5,000,004.00 
$0.00 
Equity 
5
2022-11-04 
$20,000,000.00 
$20,000,000.00 
$0.00 
Equity 
4
2019-03-13 
$1,250,000.00 
$1,250,000.00 
$0.00 
Equity, Debt 
3
2014-10-14 
$9,000,000.00 
$12,500,000.00 
$3,500,000.00 
Equity 
2
2014-08-20 
$4,742,648.00 
$4,742,648.00 
$0.00 
Equity 
1
2014-02-04 
$3,225,000.00 
$3,225,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS 
 
ADAMS 
DIRECTOR
SYNERGY PHARMACEUTICALS, INC.   |  TROVAGENE INC.   |  TROVAGENE, INC.   |  CONTRAVIR PHARMACEUTICALS, INC.   |  CARDIFF ONCOLOGY, INC.   |  60 DECIBELS, INC.   |  SALUTE LOANS LLC
SIREESH 
 
APPAJOSYULA 
DIRECTOR
THARIMMUNE, INC.   |  CANTON STRATEGIC HOLDINGS, INC.   |  HEPION PHARMACEUTICALS, INC.
TIMOTHY 
 
BLOCK 
DIRECTOR
HARVEY SPV1 LLC   |  CONTRAVIR PHARMACEUTICALS, INC.   |  HEPION PHARMACEUTICALS, INC.
JOHN 
 
BRANCACCIO 
DIRECTOR
SYNERGY PHARMACEUTICALS, INC.   |  SYNERGY PHARMACEUTICALS, INC.   |  TROVAGENE INC.   |  ORCHESTRA CALIBER CO-INVESTMENT PARTNERS, LLC   |  CORBUS PHARMACEUTICALS HOLDINGS, INC.   |  SAV ACQUISITION CORP   |  SAV HOLDINGS CORP.   |  TAMIR BIOTECHNOLOGY, INC.   |  CONTRAVIR PHARMACEUTICALS, INC.   |  ADGERO BIOPHARMACEUTICALS HOLDINGS, INC.   |  RASNA THERAPEUTICS INC.   |  TROVAGENE, INC.   |  CARDIFF ONCOLOGY, INC.
JOHN 
P. 
BRANCACCIO 
DIRECTOR
ALFACELL CORP   |  TAMIR BIOTECHNOLOGY, INC.   |  CONTRAVIR PHARMACEUTICALS, INC.   |  TROVAGENE, INC.   |  HEPION PHARMACEUTICALS, INC.
JOHN 
 
CAVAN 
EXECUTIVE OFFICER
CONTRAVIR PHARMACEUTICALS, INC.   |  HEPION PHARMACEUTICALS, INC.
BERNARD 
F. 
DENOYER 
EXECUTIVE OFFICER, DIRECTOR
CONTRAVIR PHARMACEUTICALS, INC.
ROBERT 
 
FOSTER 
EXECUTIVE OFFICER, DIRECTOR
PRECISION DYNAMICS CORP   |  DOCENTER INC   |  CICLOFILIN PHARMACEUTICALS INC.   |  MICHIGAN CRITICAL CARE CONSULTANTS, INC.   |  CONTRAVIR PHARMACEUTICALS, INC.   |  ANTHEM SPORTS + ENTERTAINMENT INC.   |  HEPION PHARMACEUTICALS, INC.   |  CENTRAL OHIO BANCORP
TODD 
 
HOBBS 
EXECUTIVE OFFICER
HEPION PHARMACEUTICALS, INC.
BILL 
 
HORNUNG 
EXECUTIVE OFFICER
CONTRAVIR PHARMACEUTICALS, INC.
GARY 
 
JACOB 
DIRECTOR
SYNERGY PHARMACEUTICALS, INC.   |  TROVAGENE INC.   |  CONTRAVIR PHARMACEUTICALS, INC.   |  TROVAGENE, INC.   |  CARDIFF ONCOLOGY, INC.
GARY 
S. 
JACOB 
EXECUTIVE OFFICER, DIRECTOR
SYNERGY PHARMACEUTICALS, INC.   |  CONTRAVIR PHARMACEUTICALS, INC.   |  TROVAGENE, INC.   |  HEPION PHARMACEUTICALS, INC.
GARY 
S. 
JACOBS 
DIRECTOR
HEPION PHARMACEUTICALS, INC.
KAOUTHAR 
 
LBIATI 
DIRECTOR
HEPION PHARMACEUTICALS, INC.   |  THERALASE TECHNOLOGIES INC /FI
ARNOLD 
 
LIPPA 
DIRECTOR
CONTRAVIR PHARMACEUTICALS, INC.   |  HEPION PHARMACEUTICALS, INC.
CHASE 
 
LOPRIORE 
DIRECTOR
HEPION PHARMACEUTICALS, INC.
VINCENT 
 
LOPRIORE 
EXECUTIVE OFFICER, DIRECTOR
THARIMMUNE, INC.   |  CANTON STRATEGIC HOLDINGS, INC.   |  HEPION PHARMACEUTICALS, INC.
CHRISTOPHER 
 
MCGUIGAN 
DIRECTOR
SYNERGY PHARMACEUTICALS, INC.   |  CONTRAVIR PHARMACEUTICALS, INC.
MICHAEL 
 
PURCELL 
DIRECTOR
FEMMEPHARMA CONSUMER HEALTHCARE, LLC   |  TABULA RASA HEALTHCARE, INC.   |  HEPION PHARMACEUTICALS, INC.
ANAND 
 
REDDI 
DIRECTOR
HEPION PHARMACEUTICALS, INC.
JAMES 
 
SAPIRSTEIN 
EXECUTIVE OFFICER, DIRECTOR
TOBIRA THERAPEUTICS, INC.   |  ALLIQUA, INC.   |  CONTRAVIR PHARMACEUTICALS, INC.   |  AZURRX BIOPHARMA, INC.   |  MARIZYME INC   |  FIRST WAVE BIOPHARMA, INC.   |  RENOVARO INC.   |  ONCONETIX, INC.
GARY 
 
STETZ 
EXECUTIVE OFFICER, DIRECTOR
BCB BANCORP INC   |  THARIMMUNE, INC.   |  CANTON STRATEGIC HOLDINGS, INC.   |  HEPION PHARMACEUTICALS, INC.
PETRUS 
 
WIJNGAARD 
DIRECTOR
HEPION PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-04-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-04-21 
2024-07-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2024-07-19 
2023-10-03
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-09-28 
2022-11-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-11-04 
2019-03-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2019-03-13 
2014-10-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2014-10-14 
2014-08-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2014-08-20 
2014-02-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2014-02-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
A.G.P./ALLIANCE GLOBAL PARTNERS
000008361
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
000119037
NONE
NONE
A.G.P./ALLIANCE GLOBAL PARTNERS
8361
NONE
NONE
A.G.P./ ALLIANCE GLOBAL PARTNERS
8361